Sonus Finds Way Out through Merger with OncoGenex
By Sally Mardikian PhD
Pharma Deals Review: Vol 2008 Issue 96 (Table of Contents)
Published: 29 May-2008
DOI: 10.3833/pdr.v2008.i96.179 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Sonus Pharmaceuticals has overcome disappointing Phase III failure in late 2007 by merging with OncoGenex to form OncoGenex Pharmaceuticals, a company with an array of promising oncology clinical candidates...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018